课题基金 / 基金详情

Molecular Mechanisms of Lung Inflammation

Molecular Mechanisms of Lung Inflammation
肺部炎症的分子机制
批准号:
8701335
负责人:
Mark Damian Wewers
金额:
$26.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2018-06-30

项目摘要

项目成果

Mark Damian Wewers的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Lung inflammation is central to the most lung diseases which include pneumonia, bronchitis, asthma, fibrosis and emphysema. Understanding the molecular mechanisms underlying these diseases is critical to our future success in developing new treatment strategies. This NRSA competitive renewal is designed to bring new basic and clinical medical scientists together to study in a research intensive environment with the goal of generating the next generation of investigators working to understand, prevent and treat lung disease. This T32 utilizes the infrastructure of the Ohio State University's Davis Heart and Lung Research Institute, the OSU Pulmonary Allergy Critical Care and Sleep Medicine Division, the Center for Microbial Interface Biology and the training programs of the OSU NIH Center for Translational Sciences Award to provide the training platforms. We have formed a training faculty with broad backgrounds to support specific experience opportunities in lung host defense, apoptosis injury and repair, molecular genetics, cell signaling, and translational medicine. Our plan is to recruit 2 postdoctoral Ph.D. and 2 M.D. trainees at a time into a 2 year program that provides an innovative experience that breeds interdisciplinary understanding and links these trainees with both junior and senior faculty in an intensive and creative environment that promotes future research careers in lung disease. Specifically the objectives of the program are fourfold. Objective 1. To provide sufficient didacti, interactive and technical background in molecular biology, immunology, cell signaling, proteomics and functional genomics to allow trainees to be able to move easily between these disciplines and to be able to translate their knowledge into further understanding of the origins o pulmonary disease. Objective 2. To develop an innovative program which ensures that trainees move rapidly into laboratory experiences that are likely to be successful. Furthermore, by using peer review and interdisciplinary faculty oversight, we will instill in the trainees a consistent momentum and focus on their chosen research topics throughout the training period. Objective 3. To immerse the trainees in a creative environment and positive research atmosphere which ensures the greatest possibility for success and retention in the ranks of scientific investigators and teachers. In addition, specific training will be provided in the ethics and philosophy of research with the intent of producing scientists who will operate at the highest levels of intellectual integrity. Objective 4. To develop long-range programs which encourage women and minorities to pursue careers in pulmonary science and research and more importantly, to build sufficient infrastructure and support systems within the training program to ensure the success of the motivated trainee. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of lung host defense by inflammasome modifiers
  • 批准号:
    8048861
  • 项目类别:
  • 资助金额:
    $19.06万
  • 财政年份:
    2010
  • 负责人:
    Mark Damian Wewers
  • 依托单位:
Regulation of lung host defense by inflammasome modifiers
  • 批准号:
    8204686
  • 项目类别:
  • 资助金额:
    $22.88万
  • 财政年份:
    2010
  • 负责人:
    Mark Damian Wewers
  • 依托单位:
RIP2 caspase-1 signaling in macrophages
  • 批准号:
    7583471
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2009
  • 负责人:
    Mark Damian Wewers
  • 依托单位:
RIP2 caspase-1 signaling in macrophages
  • 批准号:
    8024493
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2009
  • 负责人:
    Mark Damian Wewers
  • 依托单位:
国内基金
海外基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
Molecular Plant
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
Molecular Plant